| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K44224150 |
| PharmacoGx | BRD-K44224150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-09 |
| mRNA | PPP1R3F | CTRPv2 | pan-cancer | AAC | 0.43 | 2e-09 |
| mRNA | TP53I11 | CTRPv2 | pan-cancer | AAC | 0.41 | 4e-09 |
| mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.41 | 5e-09 |
| mRNA | PCDH8 | CTRPv2 | pan-cancer | AAC | 0.41 | 6e-09 |
| mRNA | TPBGL | CTRPv2 | pan-cancer | AAC | 0.41 | 7e-09 |
| mRNA | PDZD4 | CTRPv2 | pan-cancer | AAC | 0.42 | 7e-09 |
| mRNA | MAGEE1 | CTRPv2 | pan-cancer | AAC | 0.43 | 8e-09 |
| mRNA | PRDM8 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-08 |
| mRNA | TPO | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-08 |
